Home › Funds › Transmarket Holdings LP › APGE

Transmarket Holdings LP position in APGE

APOGEE THERAPEUTICS INC

Transmarket Holdings LP reported holding 34,493 shares of APGE (APOGEE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.6M, representing 3.36% of its reported portfolio and ranking #16 among its reported holdings. Transmarket Holdings LP first reported this position in Q2 2026.

Latest position (Q2 2026)34.49K sh
Reported value held$4.58M
Portfolio Weight3.36%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

How Transmarket Holdings LP's APGE position evolved

Transmarket Holdings LP first disclosed a stake in APGE in Q2 2026 at 34,493 shares (US$4.6M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 34.49K $4.58M New

About APGE and 13F data

APGE (APOGEE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 60 other funds we track also report a position in APGE — the largest reported positions include Venrock Adviser, LLC (US$1.13B), HBK INVESTMENTS L P (US$378.3M), DRIEHAUS CAPITAL MANAGEMENT LLC (US$231.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding APGE

All APGE fund holders →